New Key Statistics Module, Z-Score and F-Score
NAS:ARCT Key Ratios
Market Cap $ M | 714.60 |
Enterprise Value $ M | 452.81 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.56 |
Price/Sales | 4.53 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 157.00 |
EPS (TTM) $ | -1.16 |
Beneish M-Score | 9.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -262.10 |
EV-to-EBIT | -16.69 |
EV-to-EBITDA | -18.74 |
PEG | -- |
Shares Outstanding M | 26.92 |
Net Margin (%) | -18.84 |
Operating Margin % | -49.58 |
Pre-tax Margin (%) | -17.68 |
Quick Ratio | 4.72 |
Current Ratio | 4.72 |
ROA % (ttm) | -6.64 |
ROE % (ttm) | -10.30 |
ROIC % (ttm) | -68.55 |
Dividend Yield % | -- |
Altman Z-Score | 2.65 |
ARCT Number of Guru Trades
ARCT Volume of Guru Trades
Gurus Latest Trades with NAS:ARCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARCT is held by these investors
Total 1
Arcturus Therapeutics Holdings Inc Insider Transactions
No Available Data
News about NAS:ARCT
Total 0- 1